S&P 5007,428.78▲0.2% Nasdaq24,876.91▼0.2% Dow52,747.32▲1.0% Russell 2K2,953.80▲0.2% 10-Yr4.60%−4bp VIX18.21−0.46 WTI$81.23▼1.7% Gold$4,023.80▼1.2% EUR/USD1.139▼0.1% BTC$63,755▼0.2% Nikkei64,931▲0.5%
At close · Tue, Jul 28, 2026
Daily Market Updates.

Earnings

Home›Earnings›Results›Drugmakers rise after Q2 results, despite at least one…

Drugmakers rise after Q2 results, despite at least one profit miss

Wednesday, July 29, 2026 · Written up by our desk · Results

Drugmakers moved higher following their second-quarter reports, with gains driven by results from multiple companies, according to Yahoo Finance.

The coverage noted that the group’s broad advance came even as one drugmaker missed its profit outlook for the quarter, suggesting mixed earnings among peers.

Overall, the move reflected market reaction to both the beats and misses coming out of the sector’s Q2 reporting cycle, the outlet said.

← Newer storyRobinhood earnings due soon, with key items in focus

More like this

EarningsMeta reports second-quarter results, investors seek clarity on diversification
EarningsSoFi shares slide after earnings and revenue miss estimates
EarningsHumana beats quarterly estimates and keeps 2026 profit outlook
EarningsCarrier shares slide after Q2 beat as margins compress
EarningsThe Hanover reports $191.6m second-quarter net income on improving ratios

Sources

Yahoo FinanceDrugmakers Climb On Q2 Reports, Even As One Misses Profit Views

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.